Skip to main content
. 2026 Jul 24;7(4):85. doi: 10.3390/neurosci7040085
AE Adverse Event
AChR Acetylcholine Receptor
AChR-Ab Anti-Acetylcholine Receptor Antibody
AZA Azathioprine
CBA Cell-Based Assay
gMG Generalized Myasthenia Gravis
IS Immunosuppressant(s)
IV Intravenously
IVIg Intravenous Immunoglobulin
MAC Membrane Attack Complex
MCID Minimal Clinically Important Difference
MG Myasthenia Gravis
MG-ADL Myasthenia Gravis Activities of Daily Living
MGFA Myasthenia Gravis Foundation of America
MMF Mycophenolate Mofetil
MMS Minimal Manifestations Status
NMJ Neuromuscular Junction
PLEX Plasma Exchange
QMG Quantitative Myasthenia Gravis
RIA Radio-Immunoassay
SD Standard Deviation